SS-31

$50.00

SS-31 (Elamipretide) is a synthetic mitochondria-targeted tetrapeptide that selectively binds cardiolipin on the inner mitochondrial membrane, stabilizing cristae structure, reducing oxidative stress, and enhancing ATP production. It received FDA accelerated approval in September 2025 as Forzinity, the first approved therapy for Barth syndrome. It is also under investigation for primary mitochondrial myopathy, age-related macular degeneration, heart failure, and renal injury. Not approved for general anti-aging or performance use.